NCT00586885View on ClinicalTrials.gov

Effects of Alanine in Patients With Nonalcoholic Steatohepatitis

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Nonalcoholic Steatohepatitis
Interventions
DRUG

L-alanine

6g of L-alanine (powder)once per day for the first month, twice per day for the second month, then three times per day from the third month for 10 months.

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
collaborator

Ajinomoto USA, INC.

INDUSTRY

lead

Keith D Lindor, M.D.

OTHER

NCT00586885 - Effects of Alanine in Patients With Nonalcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter